Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review – Journal of Intensive Care

A growing body of evidence supports the use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) refractory to maximal medical therapy. ARDS may develop in a proportion of patients hospitalized for coronavirus disease 2019 (COVID-19) and ECMO may be used to manage patients refractory to maximal medical therapy to mitigate the risk of…

Read the full article here

Related Articles